학술논문
390P - A phase I study of durvalumab (D) in combination with olaparib (O) and cediranib (C) in recurrent women’s cancers
Document Type
Abstract
Author
Zimmer, A. ; Peer, C. ; Cao, L. ; Kohn, E. ; Lipkowitz, S. ; Annunziata, C. ; Trepel, J. ; Lee, M-J. ; Mikkilineni, L. ; Gatti-Mays, M. ; Nunes, A. ; Soltani, S. ; Figg, W.D. ; Houston, N. ; Nichols, E. ; Lee, J-M.
Source
In Annals of Oncology September 2017 28 Supplement 5:v130-v130
Subject
Language
ISSN
0923-7534